Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02589444 · ClinicalTrials.gov registry record · NA
Vitamin D and Microbiota in Cystic Fibrosis
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02589444: Completed NA study, sponsored by Emory University.
NCT02589444 is a NA study that has completed, run by Emory University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02589444, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The objective of this study is to assess the effects of a high-dose vitamin D3 on the composition of gut and lung microbiota in adolescents and adults with cystic fibrosis who are vitamin D deficient.
Primary Outcome
Sputum microbiota analysis will be measured using this ecological diversity measure. Sputum samples will be collected via a sputum kit.
Interventions
- PROCEDURE Blood draw
- OTHER Sham Comparator
- OTHER Stool Sample
- DIETARY_SUPPLEMENT High-Dose Vitamin D3
- OTHER Sputum Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-04 |
| Phase | NA |
What the finished NCT02589444 record still lists
NCT02589444 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Blood draw is the first listed.
NCT02589444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02589444 about?
NCT02589444 is a clinical study titled "Vitamin D and Microbiota in Cystic Fibrosis". The objective of this study is to assess the effects of a high-dose vitamin D3 on the composition of gut and lung microbiota in adolescents and adults with cystic fibrosis who are vitamin D deficient.
What is the current status of trial NCT02589444?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-12. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02589444?
The interventions under investigation include: Blood draw (PROCEDURE), Sham Comparator (OTHER), Stool Sample (OTHER), High-Dose Vitamin D3 (DIETARY_SUPPLEMENT), Sputum Sample (OTHER).
Who is sponsoring clinical trial NCT02589444?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02589444's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia